The ABRYSVO RSV vaccine is for pregnant people at 32 through 36 weeks (about 8
and 8 ½ months), people ages 60 years and older, and adults who are at a higher risk for severe illness from RSV.
The vaccine can protect infants under six months of age from potentially life-threatening lower respiratory tract disease (LRTD). ABRYSVO can also protect older adults over 60 years of age from severe RSV and LRTD which, if left untreated, can result in hospitalization.
Download our fact sheet to learn more.